Stock comparison
Twist Bioscience
TWST$3.77BHealthcare Market cap, Sector
United Therapeutics
UTHR$24.13BHealthcare Market cap, Sector
Overall winner
United Therapeutics
TWST 07 UTHR
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
TWST0wins
7winsUTHR
29F
B71
52D
B76
51D
B76
45D
C62
0F
D46
35F
C64
40F
C64
Side-by-side metrics
| Metric | TWST | UTHR |
|---|---|---|
| Market cap | $3.77B | $24.13B Winner |
| P/E (TTM) | Winner: - | 19.2x |
| EV/EBIT | Winner: - | 15.2x |
| ROIC (TTM) | -24.5% | 18.81% Winner |
| Gross margin | 52.07% | 86.58% Winner |
| Net margin | -19.85% | 40.61% Winner |
| Revenue CAGR 5y | Winner: 29.88% | 17.22% |
| EPS CAGR 5y | - | 29.84% |
| Debt / Equity | 0.2x | - Winner |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
TWST leads on
- EV/EBIT-vs 15.2x+160%
- P/E (TTM)-vs 19.2x+145%
- Revenue CAGR 5y29.88%vs 17.22%+42%
UTHR leads on
- ROIC (TTM)18.81%vs -24.5%+177%
- Net margin40.61%vs -19.85%+149%
- Debt / Equity-vs 0.2x+100%
- Market cap$24.13Bvs $3.77B+84%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.